Otsu, Japan

Atsuhiko Okita

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Nippon Shinyaku Company, Ltd.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atsuhiko Okita. Retrieved from https://idiyas.com/inventor/atsuhiko-okita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Atsuhiko Okita: Innovator in Drug Delivery Systems

Introduction

Atsuhiko Okita is a prominent inventor based in Otsu, Japan. He has made significant contributions to the field of drug delivery systems, focusing on improving the efficacy of drug administration.

Latest Patents

Okita holds a patent for a novel drug carrier that enhances drug delivery. This innovative drug carrier comprises a fat or fatty emulsion as a core, with a surface layer that optimizes the delivery process. The core constitutes 30% to 65% of the formulation, while the surface layer makes up 35% to 70%. The emulsion is characterized by a mean particle diameter of less than 100 nm, which contributes to its effectiveness in drug delivery.

Career Highlights

Atsuhiko Okita is associated with Nippon Shinyaku Company, Ltd., where he continues to develop groundbreaking solutions in the pharmaceutical industry. His work has garnered attention for its potential to improve patient outcomes through enhanced drug delivery mechanisms.

Collaborations

Okita collaborates with notable colleagues, including Makoto Sugiyama and Junzo Seki, who contribute to his research and development efforts.

Conclusion

Atsuhiko Okita's innovative work in drug delivery systems exemplifies the impact of targeted research in pharmaceuticals. His contributions are paving the way for advancements that could significantly benefit healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…